GLP-1 / Metabolic

Cagrilintide

Cagrilintide (NN9838)

Long-acting amylin analog by Novo Nordisk. Studied with semaglutide as CagriSema.

Typical dose

1–4.5 mg

Frequency

Once weekly

Half-life

—

Route

subcutaneous

Typical vial sizes

5 mg

Sample reconstitution

5 mg vial · 2 mL bac water · 2.75 mg dose

Draw volume: 1.100 mL
Insulin units: 110 units
Concentration: 2.50 mg/mL
Doses per vial: 1.8

Open full calculator →

Research use only.

Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.